Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 141

1.

Bad bug, no test: Tigecycline susceptibility testing challenges and way forward.

Shankar C, Pragasam AK, Veeraraghavan B, Amladi A.

Indian J Med Microbiol. 2019 Jan-Mar;37(1):91-94. doi: 10.4103/ijmm.IJMM_19_207.

2.

Colistin-sparing approaches with newer antimicrobials to treat carbapenem-resistant organisms: Current evidence and future prospects.

Veeraraghavan B, Pragasam AK, Bakthavatchalam YD, Anandan S, Swaminathan S, Sundaram B.

Indian J Med Microbiol. 2019 Jan-Mar;37(1):72-90. doi: 10.4103/ijmm.IJMM_19_215. Review.

3.

Will ceftazidime/avibactam plus aztreonam be effective for NDM and OXA-48-Like producing organisms: Lessons learnt from In vitro study.

Pragasam AK, Veeraraghavan B, Shankar BA, Bakthavatchalam YD, Mathuram A, George B, Chacko B, Korula P, Anandan S.

Indian J Med Microbiol. 2019 Jan-Mar;37(1):34-41. doi: 10.4103/ijmm.IJMM_19_189.

4.

Indian consensus on the management of CRE infection in critically ill patients (ICONIC) - India.

Soman R, Veeraraghavan B, Hegde A, Jiandani P, Mehta Y, Nagavekar V, Rodrigues C, Singh RK, Swaminathan S, Todi S, Varma S, Patil S, Barkate H.

Expert Rev Anti Infect Ther. 2019 Aug;17(8):647-660. doi: 10.1080/14787210.2019.1647103. Epub 2019 Aug 2.

PMID:
31375039
5.

Extremely High Mortality Rates in Patients with Carbapenem-resistant, Hypermucoviscous Klebsiella pneumoniae Blood Stream Infections.

Shankar C, Nabarro LE, Anandan S, Ravi R, Babu P, Munusamy E, Jeyaseelan V, Rupali P, Verghese VP, Veeraraghavan B.

J Assoc Physicians India. 2018 Dec;66(12):13-16.

PMID:
31313543
6.

Nasopharyngeal carriage of Streptococcus pneumoniae serotypes among children in India prior to the introduction of pneumococcal conjugate vaccines: a cross-sectional study.

Sutcliffe CG, Shet A, Varghese R, Veeraraghavan B, Manoharan A, Wahl B, Chandy S, Sternal J, Khan R, Singh RK, Santosham M, Arora NK.

BMC Infect Dis. 2019 Jul 10;19(1):605. doi: 10.1186/s12879-019-4254-2.

7.

Accurate identification of clinically important Acinetobacter spp.: an update.

Vijayakumar S, Biswas I, Veeraraghavan B.

Future Sci OA. 2019 Jun 27;5(6):FSO395. doi: 10.2144/fsoa-2018-0127. Review.

8.

Rapidly disseminating blaOXA-232 carrying Klebsiella pneumoniae belonging to ST231 in India: multiple and varied mobile genetic elements.

Shankar C, Mathur P, Venkatesan M, Pragasam AK, Anandan S, Khurana S, Veeraraghavan B.

BMC Microbiol. 2019 Jun 24;19(1):137. doi: 10.1186/s12866-019-1513-8.

9.

Virulence gene profiles of Shigella species isolated from stool specimens in India: its association with clinical manifestation and antimicrobial resistance.

Sethuvel DPM, Anandan S, Michael JS, Murugan D, Neeravi A, Verghese VP, Walia K, Veeraraghavan B.

Pathog Glob Health. 2019 Jun 21:1-7. doi: 10.1080/20477724.2019.1632062. [Epub ahead of print]

PMID:
31221039
10.

Antimicrobial resistance, virulence & plasmid profiles among clinical isolates of Shigella serogroups.

Sethuvel DPM, Perumalla S, Anandan S, Michael JS, Ragupathi NKD, Gajendran R, Walia K, Veeraraghavan B.

Indian J Med Res. 2019 Feb;149(2):247-256. doi: 10.4103/ijmr.IJMR_2077_17.

11.

Molecular characterization & epidemiology of carbapenem-resistant Acinetobacter baumannii collected across India.

Vijayakumar S, Mathur P, Kapil A, Das BK, Ray P, Gautam V, Sistla S, Parija SC, Walia K, Ohri VC, Anandan S, Subramani K, Ramya I, Veeraraghavan B.

Indian J Med Res. 2019 Feb;149(2):240-246. doi: 10.4103/ijmr.IJMR_2085_17.

12.

Plasmid profiles among some ESKAPE pathogens in a tertiary care centre in south India.

Ragupathi NKD, Bakthavatchalam YD, Mathur P, Pragasam AK, Walia K, Ohri VC, Veeraraghavan B.

Indian J Med Res. 2019 Feb;149(2):222-231. doi: 10.4103/ijmr.IJMR_2098_17.

13.

Molecular characterization of extended-spectrum β-lactamases among clinical isolates of Escherichia coli & Klebsiella pneumoniae: A multi-centric study from tertiary care hospitals in India.

Gautam V, Thakur A, Sharma M, Singh A, Bansal S, Sharma A, Kapil A, Das BK, Sistla S, Parija SC, Veeraraghavan B, Prakash JAJ, Walia K, Ohri VC, Ray P.

Indian J Med Res. 2019 Feb;149(2):208-215. doi: 10.4103/ijmr.IJMR_172_18.

14.

Molecular characterization of colistin-resistant Klebsiella pneumoniae & its clonal relationship among Indian isolates.

Shankar C, Venkatesan M, Rajan R, Mani D, Lal B, Prakash JAJ, Anandan S, Pragasam AK, Walia K, Ohri VC, Veeraraghavan B.

Indian J Med Res. 2019 Feb;149(2):199-207. doi: 10.4103/ijmr.IJMR_2087_17.

15.

Susceptibility profile, resistance mechanisms & efficacy ratios of fosfomycin, nitrofurantoin & colistin for carbapenem-resistant Enterobacteriaceae causing urinary tract infections.

Amladi AU, Abirami B, Devi SM, Sudarsanam TD, Kandasamy S, Kekre N, Veeraraghavan B, Sahni RD.

Indian J Med Res. 2019 Feb;149(2):185-191. doi: 10.4103/ijmr.IJMR_2086_17.

16.

Establishing Antimicrobial Resistance Surveillance & Research Network in India: Journey so far.

Walia K, Madhumathi J, Veeraraghavan B, Chakrabarti A, Kapil A, Ray P, Singh H, Sistla S, Ohri VC.

Indian J Med Res. 2019 Feb;149(2):164-179. doi: 10.4103/ijmr.IJMR_226_18.

17.
18.

Genomic analysis of human invasive Salmonella enterica serovar Typhimurium ST313 isolate B3589 from India.

Jacob JJ, Anandan S, Venkatesan M, Neeravi A, Vasudevan K, Pragasam AK, Veeraraghavan B.

Infect Genet Evol. 2019 Jun 3;73:416-424. doi: 10.1016/j.meegid.2019.05.023. [Epub ahead of print]

PMID:
31170530
19.

Evaluation of risk factors for colistin resistance among uropathogenic isolates of Escherichia coli and Klebsiella pneumoniae: a case-control study.

Kaza P, Mahindroo J, Veeraraghavan B, Mavuduru RS, Mohan B, Taneja N.

J Med Microbiol. 2019 Jun;68(6):837-847. doi: 10.1099/jmm.0.000986. Epub 2019 May 14.

PMID:
31084700
20.

Impact of an antimicrobial stewardship intervention in India: Evaluation of post-prescription review and feedback as a method of promoting optimal antimicrobial use in the intensive care units of a tertiary-care hospital.

Rupali P, Palanikumar P, Shanthamurthy D, Peter JV, Kandasamy S, Zacchaeus NGP, Alexander H, Thangavelu P, Karthik R, Abraham OC, Michael JS, Paul H, Veeraraghavan B, Chacko B, Jeyaseelan V, Alangaden G, Prentiss T, Zervos MJ.

Infect Control Hosp Epidemiol. 2019 May;40(5):512-519. doi: 10.1017/ice.2019.29.

PMID:
31084674
21.

Current Perspectives on Treatment of Gram-Positive Infections in India: What Is the Way Forward?

Kulkarni AP, Nagvekar VC, Veeraraghavan B, Warrier AR, Ts D, Ahdal J, Jain R.

Interdiscip Perspect Infect Dis. 2019 Apr 7;2019:7601847. doi: 10.1155/2019/7601847. eCollection 2019. Review.

22.

Emergence of ST147 Klebsiella pneumoniae carrying blaNDM-7 on IncA/C2 with ompK35 and ompK36 mutations in India.

Shankar C, Kumar S, Venkatesan M, Veeraraghavan B.

J Infect Public Health. 2019 Apr 16. pii: S1876-0341(19)30133-9. doi: 10.1016/j.jiph.2019.03.023. [Epub ahead of print]

23.

Highly accurate-single chromosomal complete genomes using IonTorrent and MinION sequencing of clinical pathogens.

Vasudevan K, Devanga Ragupathi NK, Jacob JJ, Veeraraghavan B.

Genomics. 2019 Apr 10. pii: S0888-7543(19)30058-8. doi: 10.1016/j.ygeno.2019.04.006. [Epub ahead of print]

PMID:
30978388
24.

mgrB as Hotspot for Insertion Sequence Integration: Change Over from Multidrug-Resistant to Extensively Drug-Resistant Klebsiella pneumoniae?

Shankar C, Pragasam AK, Anandan S, Veeraraghavan B.

Microb Drug Resist. 2019 Apr 4. doi: 10.1089/mdr.2018.0415. [Epub ahead of print] No abstract available.

PMID:
30946628
25.

Horizontal Transfer of Antimicrobial Resistance Determinants Among Enteric Pathogens Through Bacterial Conjugation.

Devanga Ragupathi NK, Muthuirulandi Sethuvel DP, Gajendran R, Anandan S, Walia K, Veeraraghavan B.

Curr Microbiol. 2019 Jun;76(6):666-672. doi: 10.1007/s00284-019-01676-x. Epub 2019 Apr 2.

PMID:
30941540
26.

A New Method for Determination of Minimum Biofilm Eradication Concentration for Accurate Antimicrobial Therapy.

Ravi NS, Aslam RF, Veeraraghavan B.

Methods Mol Biol. 2019;1946:61-67. doi: 10.1007/978-1-4939-9118-1_6.

PMID:
30798544
27.

Antimicrobial Susceptibility Testing Methods for Acinetobacter spp.

Veeraraghavan B, Vijayakumar S, Pragasam AK, Bakthavachalam YD, Prakash JAJ.

Methods Mol Biol. 2019;1946:23-37. doi: 10.1007/978-1-4939-9118-1_3.

PMID:
30798541
28.

Genotyping of Acinetobacter baumannii in Nosocomial Outbreak and Surveillance.

Vijayakumar S, Veeraraghavan B, Pragasam AK, Bakthavachalam YD.

Methods Mol Biol. 2019;1946:17-22. doi: 10.1007/978-1-4939-9118-1_2.

PMID:
30798540
29.

Specimen Collection, Processing, Culture, and Biochemical Identification of Acinetobacter spp.

Lal B, Vijayakumar S, Anandan S, Veeraraghavan B.

Methods Mol Biol. 2019;1946:1-15. doi: 10.1007/978-1-4939-9118-1_1.

PMID:
30798539
30.

An invasive marker Staphylococcus epidermidis surface protein I (SesI) harboured by a ST239 methicillin-resistant Staphylococcus aureus.

Bakthavatchalam YD, Arumugam A, Veeraraghavan B.

J Glob Antimicrob Resist. 2019 Feb 21;18:122-125. doi: 10.1016/j.jgar.2019.02.006. [Epub ahead of print]

PMID:
30797090
31.

Efficacy ratio: A tool to enhance optimal antimicrobial use for intra-abdominal infections.

Sabu P, Elangovan D, Pragasam AK, Bakthavatchalam YD, Rodrigues C, Chitnis DS, Chaudhuri BN, Veeraraghavan B.

Indian J Pharmacol. 2018 Nov-Dec;50(6):332-335. doi: 10.4103/ijp.IJP_264_18.

32.

A Distinct Geographic Variant of sasX in Methicillin-Resistant Staphylococcus aureus ST239 and ST368 Lineage from South India.

Bakthavatchalam YD, Triplicane Dwarakanathan H, Munusamy E, Jennifer L, Veeraraghavan B.

Microb Drug Resist. 2019 Apr;25(3):413-420. doi: 10.1089/mdr.2018.0292. Epub 2019 Feb 14.

PMID:
30762476
33.

Can the imaging manifestations of melioidosis prognosticate the clinical outcome? A 6-year retrospective study.

Khiangte HL, Robinson Vimala L, Veeraraghavan B, Yesudhason BL, Karuppusami R.

Insights Imaging. 2019 Feb 13;10(1):17. doi: 10.1186/s13244-019-0708-8.

34.

Extensive drug resistant Salmonella enterica serovar Senftenberg carrying blaNDM encoding plasmid p5558 (IncA/C) from India.

Veeraraghavan B, Jacob JJ, Prakash JAJ, Pragasam AK, Neeravi A, Narasimman V, Anandan S.

Pathog Glob Health. 2019 Feb;113(1):20-26. doi: 10.1080/20477724.2019.1574112. Epub 2019 Feb 6.

PMID:
30722761
35.

Accurate identification and epidemiological characterization of Burkholderia cepacia complex: an update.

Devanga Ragupathi NK, Veeraraghavan B.

Ann Clin Microbiol Antimicrob. 2019 Feb 4;18(1):7. doi: 10.1186/s12941-019-0306-0. Review.

36.

Clinical Manifestations, Antimicrobial Drug Susceptibility Patterns, and Outcomes in Melioidosis Cases, India.

Koshy M, Jagannati M, Ralph R, Victor P, David T, Sathyendra S, Veeraraghavan B, Varghese GM.

Emerg Infect Dis. 2019 Feb;25(2):316-320. doi: 10.3201/eid2502.170745.

37.

Evidence from an In Vitro Study: Is Oxacillin Plus Vancomycin a Better Choice for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus?

Bakthavatchalam YD, Ralph R, Veeraraghavan B, Babu P, Munusamy E.

Infect Dis Ther. 2019 Mar;8(1):51-62. doi: 10.1007/s40121-018-0224-z. Epub 2018 Nov 21.

38.

Dominance of international high-risk clones in carbapenemase-producing Pseudomonas aeruginosa: Multicentric molecular epidemiology report from India.

Pragasam AK, Veeraraghavan B, Anandan S, Narasiman V, Sistla S, Kapil A, Mathur P, Ray P, Wattal C, Bhattacharya S, Deotale V, Subramani K, Peter JV, Hariharan TD, Ramya I, Iniyan S, Walia K, Ohri VC.

Indian J Med Microbiol. 2018 Jul-Sep;36(3):344-351. doi: 10.4103/ijmm.IJMM_18_294.

39.

Newer β-Lactam/β-Lactamase inhibitor for multidrug-resistant gram-negative infections: Challenges, implications and surveillance strategy for India.

Veeraraghavan B, Pragasam AK, Bakthavatchalam YD, Anandan S, Ramasubramanian V, Swaminathan S, Gopalakrishnan R, Soman R, Abraham OC, Ohri VC, Walia K.

Indian J Med Microbiol. 2018 Jul-Sep;36(3):334-343. doi: 10.4103/ijmm.IJMM_18_326. Review.

40.

An update on antimicrobial resistance and the role of newer antimicrobial agents for Pseudomonas aeruginosa.

Pragasam AK, Veeraraghavan B, Nalini E, Anandan S, Kaye KS.

Indian J Med Microbiol. 2018 Jul-Sep;36(3):303-316. doi: 10.4103/ijmm.IJMM_18_334. Review.

41.

First Report of Whole-Genome Sequence of Colistin-Resistant Klebsiella quasipneumoniae subsp. similipneumoniae Producing KPC-9 in India.

Shankar C, Karunasree S, Manesh A, Veeraraghavan B.

Microb Drug Resist. 2019 May;25(4):489-493. doi: 10.1089/mdr.2018.0116. Epub 2018 Nov 14.

PMID:
30427763
42.

Non-vaccine Pneumococcal Serotypes Among Children with Invasive Pneumococcal Disease.

John J, Varghese R, Lionell J, Neeravi A, Veeraraghavan B.

Indian Pediatr. 2018 Oct 15;55(10):874-876.

43.

Data on whole genome shotgun sequencing report of clinical S. maltophilia strains from India.

Devanga Ragupathi NK, Veeraraghavan B.

Data Brief. 2018 Oct 4;21:263-268. doi: 10.1016/j.dib.2018.10.005. eCollection 2018 Dec.

44.

IncFII plasmid carrying antimicrobial resistance genes in Shigella flexneri: Vehicle for dissemination.

Muthuirulandi Sethuvel DP, Anandan S, Devanga Ragupathi NK, Gajendiran R, Kuroda M, Shibayama K, Veeraraghavan B.

J Glob Antimicrob Resist. 2019 Mar;16:215-219. doi: 10.1016/j.jgar.2018.10.014. Epub 2018 Oct 18.

PMID:
30342929
45.

Epidemiological investigation and successful management of a Burkholderia cepacia outbreak in a neurotrauma intensive care unit.

Rastogi N, Khurana S, Veeraraghavan B, Yesurajan Inbanathan F, Rajamani Sekar SK, Gupta D, Goyal K, Bindra A, Sokhal N, Panda A, Malhotra R, Mathur P.

Int J Infect Dis. 2019 Feb;79:4-11. doi: 10.1016/j.ijid.2018.10.008. Epub 2018 Oct 17.

46.

Detection of chromosomal and plasmid-mediated mechanisms of colistin resistance in Escherichia coli and Klebsiella pneumoniae from Indian food samples.

Ghafur A, Shankar C, GnanaSoundari P, Venkatesan M, Mani D, Thirunarayanan MA, Veeraraghavan B.

J Glob Antimicrob Resist. 2019 Mar;16:48-52. doi: 10.1016/j.jgar.2018.09.005. Epub 2018 Sep 20.

PMID:
30244040
47.

A Retrospective Case-Control Study to Evaluate the Diagnostic Accuracy of Honeycomb Sign in Melioid Liver Abscess.

Khiangte HL, Vimala LR, Eapen A, Veeraraghavan B, Karuppusami R, Gibikote S.

Am J Trop Med Hyg. 2018 Oct;99(4):852-857. doi: 10.4269/ajtmh.18-0395.

PMID:
30141398
48.

Multiple mutations in lipid-A modification pathway & novel fosA variants in colistin-resistant Klebsiella pneumoniae.

Mathur P, Veeraraghavan B, Devanga Ragupathi NK, Inbanathan FY, Khurana S, Bhardwaj N, Kumar S, Sagar S, Gupta A.

Future Sci OA. 2018 Jul 4;4(7):FSO319. doi: 10.4155/fsoa-2018-0011. eCollection 2018 Jul.

49.

Clinical spectrum, susceptibility profile, treatment and outcome of culture-confirmed brucellosis from South India.

Mani SSR, Gunasekaran K, Iyyadurai R, Prakash JAJ, Veeraraghavan B, Mishra AK, Sabnis K, Victor PJ, Martin S, Chandiraseharan VK, Hansdak SG, Varghese GM.

Indian J Med Microbiol. 2018 Apr-Jun;36(2):289-292. doi: 10.4103/ijmm.IJMM_18_236.

50.

Typhoid fever: issues in laboratory detection, treatment options & concerns in management in developing countries.

Veeraraghavan B, Pragasam AK, Bakthavatchalam YD, Ralph R.

Future Sci OA. 2018 Jun 26;4(6):FSO312. doi: 10.4155/fsoa-2018-0003. eCollection 2018 Jul. Review.

Supplemental Content

Loading ...
Support Center